Category: Latest Articles

Treatment.com AI has acquired Rocket Doctor, a virtual care platform, to enhance its AI-powered clinical intelligence capabilities. This strategic move aims to integrate advanced AI with a successful virtual healthcare delivery system. Rocket Doctor has shown significant growth, with a 112% increase in patient volume in Alberta over the past year, serving over 36,000 patients…

The National Institute for Occupational Safety and Health (NIOSH) faces severe budget cuts and staff reductions under the Trump administration, jeopardizing its efforts to address workplace mental health. NIOSH has been pivotal in initiatives to reduce suicide rates among construction workers and combat burnout in healthcare workers. Despite some staff reinstatements after congressional pushback, the…

The FDA’s recent layoffs are causing delays in the inspection of overseas drug manufacturers. This slowdown raises concerns about medication safety. ProPublica reported on July 7 that the FDA has let go of dozens of individuals responsible for coordinating complex inspections abroad. Although some staff have been rehired, the disruption continues to affect the inspection…

Plus Therapeutics has received FDA approval to start the ReSPECT-LM dose optimization trial for its drug, REYOBIQ™, aimed at treating leptomeningeal metastases. The trial’s primary goal is to establish the optimal dosing schedule for a future registrational trial. This new study builds on the recommended Phase 2 dose identified in a completed Phase 1 trial….

Planned Parenthood, the largest abortion provider in the U.S., faces a significant financial challenge. The organization risks losing millions in Medicaid funding. This funding is crucial for providing essential health care to low-income Americans. The issue arises from new regulations in certain states. These regulations require Planned Parenthood to cease offering abortion services to continue receiving federal…